IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-47536-6.html
   My bibliography  Save this article

Wild-type IDH2 is a therapeutic target for triple-negative breast cancer

Author

Listed:
  • Jiang-jiang Li

    (Sun Yat-sen University Cancer Center)

  • Tiantian Yu

    (Sun Yat-sen University Zhongshan School of Medicine)

  • Peiting Zeng

    (Sun Yat-sen University Cancer Center)

  • Jingyu Tian

    (Sun Yat-sen University Cancer Center)

  • Panpan Liu

    (Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center)

  • Shuang Qiao

    (Sun Yat-sen University Cancer Center)

  • Shijun Wen

    (Sun Yat-sen University Cancer Center)

  • Yumin Hu

    (Sun Yat-sen University Cancer Center)

  • Qiao Liu

    (Sun Yat-sen University Cancer Center)

  • Wenhua Lu

    (Sun Yat-sen University Cancer Center)

  • Hui Zhang

    (Sun Yat-sen University Cancer Center
    Sun Yat-sen University Zhongshan School of Medicine)

  • Peng Huang

    (Sun Yat-sen University Cancer Center
    Sun Yat-sen University Zhongshan School of Medicine)

Abstract

Mutations in isocitrate dehydrogenases (IDH) are oncogenic events due to the generation of oncogenic metabolite 2-hydroxyglutarate. However, the role of wild-type IDH in cancer development remains elusive. Here we show that wild-type IDH2 is highly expressed in triple negative breast cancer (TNBC) cells and promotes their proliferation in vitro and tumor growth in vivo. Genetic silencing or pharmacological inhibition of wt-IDH2 causes a significant increase in α-ketoglutarate (α-KG), indicating a suppression of reductive tricarboxylic acid (TCA) cycle. The aberrant accumulation of α-KG due to IDH2 abrogation inhibits mitochondrial ATP synthesis and promotes HIF-1α degradation, leading to suppression of glycolysis. Such metabolic double-hit results in ATP depletion and suppression of tumor growth, and renders TNBC cells more sensitive to doxorubicin treatment. Our study reveals a metabolic property of TNBC cells with active utilization of glutamine via reductive TCA metabolism, and suggests that wild-type IDH2 plays an important role in this metabolic process and could be a potential therapeutic target for TNBC.

Suggested Citation

  • Jiang-jiang Li & Tiantian Yu & Peiting Zeng & Jingyu Tian & Panpan Liu & Shuang Qiao & Shijun Wen & Yumin Hu & Qiao Liu & Wenhua Lu & Hui Zhang & Peng Huang, 2024. "Wild-type IDH2 is a therapeutic target for triple-negative breast cancer," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-47536-6
    DOI: 10.1038/s41467-024-47536-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-47536-6
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-47536-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Balázs Győrffy & Pawel Surowiak & Jan Budczies & András Lánczky, 2013. "Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-8, December.
    2. Xi Chen & Dimitrios Iliopoulos & Qing Zhang & Qianzi Tang & Matthew B. Greenblatt & Maria Hatziapostolou & Elgene Lim & Wai Leong Tam & Min Ni & Yiwen Chen & Junhua Mai & Haifa Shen & Dorothy Z. Hu & , 2014. "XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway," Nature, Nature, vol. 508(7494), pages 103-107, April.
    3. Marco Montagner & Elena Enzo & Mattia Forcato & Francesca Zanconato & Anna Parenti & Elena Rampazzo & Giuseppe Basso & Genesio Leo & Antonio Rosato & Silvio Bicciato & Michelangelo Cordenonsi & Stefan, 2012. "SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors," Nature, Nature, vol. 487(7407), pages 380-384, July.
    4. Lei Jiang & Alexander A. Shestov & Pamela Swain & Chendong Yang & Seth J. Parker & Qiong A. Wang & Lance S. Terada & Nicholas D. Adams & Michael T. McCabe & Beth Pietrak & Stan Schmidt & Christian M. , 2016. "Reductive carboxylation supports redox homeostasis during anchorage-independent growth," Nature, Nature, vol. 532(7598), pages 255-258, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Zhen Lu & Jinyun Chen & Pengfei Yu & Matthew J. Atherton & Jun Gui & Vivek S. Tomar & Justin D. Middleton & Neil T. Sullivan & Sunil Singhal & Subin S. George & Ashley G. Woolfork & Aalim M. Weljie & , 2022. "Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    2. C. Megan Young & Laurent Beziaud & Pierre Dessen & Angela Madurga Alonso & Albert Santamaria-Martínez & Joerg Huelsken, 2023. "Metabolic dependencies of metastasis-initiating cells in female breast cancer," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    3. Michael J. P. Crowley & Bhavneet Bhinder & Geoffrey J. Markowitz & Mitchell Martin & Akanksha Verma & Tito A. Sandoval & Chang-Suk Chae & Shira Yomtoubian & Yang Hu & Sahil Chopra & Diamile A. Tavarez, 2023. "Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    4. Ming Yi & Ruoqing Zhu & Robert M Stephens, 2018. "GradientScanSurv—An exhaustive association test method for gene expression data with censored survival outcome," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-28, December.
    5. Paul A Stewart & Katja Parapatics & Eric A Welsh & André C Müller & Haoyun Cao & Bin Fang & John M Koomen & Steven A Eschrich & Keiryn L Bennett & Eric B Haura, 2015. "A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma," PLOS ONE, Public Library of Science, vol. 10(11), pages 1-18, November.
    6. Bo Yuan & Jingyuan Xiong & Chaoxiong Zhang & Yuqin Yao & Chaoxiong Zhang & Ting An & Jie Liu, 2020. "Prognostic Roles of APLNR Expression in Non-Small Cell Lung Cancer," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 27(5), pages 21089-21098, May.
    7. Yongyao Fu & Abigail Pajulas & Jocelyn Wang & Baohua Zhou & Anthony Cannon & Cherry Cheuk Lam Cheung & Jilu Zhang & Huaxin Zhou & Amanda Jo Fisher & David T. Omstead & Sabrina Khan & Lei Han & Jean-Ch, 2022. "Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    8. Elena Spina & Julia Simundza & Angela Incassati & Anupama Chandramouli & Matthias C. Kugler & Ziyan Lin & Alireza Khodadadi-Jamayran & Christine J. Watson & Pamela Cowin, 2022. "Gpr125 is a unifying hallmark of multiple mammary progenitors coupled to tumor latency," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    9. Karl K. Krull & Syed Azmal Ali & Jeroen Krijgsveld, 2024. "Enhanced feature matching in single-cell proteomics characterizes IFN-γ response and co-existence of cell states," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    10. Bo Wen & Bing Zhang, 2023. "PepQuery2 democratizes public MS proteomics data for rapid peptide searching," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    11. Lijuan Zhang & Kai Zhang & Jieyou Zhang & Jinrong Zhu & Qing Xi & Huafeng Wang & Zimu Zhang & Yingnan Cheng & Guangze Yang & Hongkun Liu & Xiangdong Guo & Dongmei Zhou & Zhenyi Xue & Yan Li & Qi Zhang, 2021. "Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
    12. Xinyuan Lei & Hsinyu Lin & Jieqi Wang & Zhanpeng Ou & Yi Ruan & Ananthan Sadagopan & Weixiong Chen & Shule Xie & Baisheng Chen & Qunxing Li & Jue Wang & Huayue Lin & Xiaofeng Zhu & Xiaoqing Yuan & Tia, 2022. "Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    13. Eui Jung Moon & Stephano S. Mello & Caiyun G. Li & Jen-Tsan Chi & Kaushik Thakkar & Jacob G. Kirkland & Edward L. Lagory & Ik Jae Lee & Anh N. Diep & Yu Miao & Marjan Rafat & Marta Vilalta & Laura Cas, 2021. "The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    14. Aitor Almanza & Katarzyna Mnich & Arnaud Blomme & Claire M. Robinson & Giovanny Rodriguez-Blanco & Sylwia Kierszniowska & Eoghan P. McGrath & Matthieu Gallo & Eleftherios Pilalis & Johannes V. Swinnen, 2022. "Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    15. Eleonora Di Piazza & Elisabetta Pandolfi & Ilaria Cacciotti & Andrea Del Fattore & Alberto Eugenio Tozzi & Aurelio Secinaro & Luca Borro, 2021. "Bioprinting Technology in Skin, Heart, Pancreas and Cartilage Tissues: Progress and Challenges in Clinical Practice," IJERPH, MDPI, vol. 18(20), pages 1-29, October.
    16. Soeun Kang & Maciek R. Antoniewicz & Nissim Hay, 2024. "Metabolic and transcriptomic reprogramming during contact inhibition-induced quiescence is mediated by YAP-dependent and YAP-independent mechanisms," Nature Communications, Nature, vol. 15(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-47536-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.